| |
NASDAQ | Common Stock
Biotech Acquisition Company does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses.
The company was incorporated in 2020 and is based in New York, New York.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
Sep 30, 21 | 0.10 | - |
Jun 30, 21 | -0.18 | - |
Mar 31, 21 | 0.09 | - |
Sep 30, 20 | -0.00 | - |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Sep 30, 22 | 0.00 Decreased by N/A% | 1.26 M Decreased by -57.12% | Increased by +N/A% Decreased by N/A% |
Jun 30, 22 | 0.00 Decreased by N/A% | 9.38 M Increased by +285.18% | Increased by +N/A% Decreased by N/A% |
Mar 31, 22 | 0.00 Decreased by N/A% | 4.68 M Increased by +83.67% | Increased by +N/A% Decreased by N/A% |
Dec 31, 21 | 0.00 Decreased by N/A% | -7.29 M Decreased by -145.61 K% | Decreased by N/A% - |
Sep 30, 21 | 0.00 - | 2.94 M - | Increased by +N/A% - |
Jun 30, 21 | 0.00 - | -5.07 M - | Decreased by N/A% - |
Mar 31, 21 | 0.00 - | 2.55 M - | Increased by +N/A% - |
Sep 30, 20 | N/A - | -5.00 K - | - - |